Mesoblast (MESO) Change in Receivables (2016 - 2025)

Mesoblast has disclosed Change in Receivables across 10 years of filings, most recently posting -$28.5 million for Q4 2025.

• Change in Receivables for Q4 2025 came in at -$28.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$9.6 million (changed N/A YoY), and the FY2025 annual result was $17.6 million, up 742.95% from the prior year.
• Change in Receivables came in at -$28.5 million for Q4 2025 at Mesoblast, down from $17.6 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $17.6 million in Q2 2025 to a low of -$28.5 million in Q4 2025.
• The 5-year median for Change in Receivables is -$1.1 million (2021), against an average of -$1.4 million.
• Across the five-year window, Change in Receivables slumped 135.61% in 2021 and surged 742.95% in 2025, its largest moves.
• Mesoblast's Change in Receivables stood at -$1.5 million in 2021, then jumped by 50.6% to -$743000.0 in 2022, then changed by 0.0% to -$743000.0 in 2023, then surged by 380.48% to $2.1 million in 2024, then slumped by 1466.22% to -$28.5 million in 2025.
• The last three Change in Receivables figures came in at -$28.5 million (Q4 2025), $17.6 million (Q2 2025), and $2.1 million (Q2 2024), per Business Quant data.